142 related articles for article (PubMed ID: 17992031)
1. Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.
Jorgenson L; Reiter PD; Freeman JE; Winston KR; Fish D; McBride LA; Handler MH
Pediatr Neurosurg; 2007; 43(6):449-55. PubMed ID: 17992031
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.
Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ
Chemotherapy; 1990; 36(2):103-8. PubMed ID: 2311439
[TBL] [Abstract][Full Text] [Related]
3. Concerning the article by Jorgenson et al., Pediatr Neurosurg 2007;43:449-455 Vancomycin disposition and penetration into ventricular fluid of the central nervous system following intravenous therapy in patients with cerebrospinal devices.
James HE
Pediatr Neurosurg; 2008; 44(5):433. PubMed ID: 18703895
[No Abstract] [Full Text] [Related]
4. Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections.
Autmizguine J; Moran C; Gonzalez D; Capparelli EV; Smith PB; Grant GA; Benjamin DK; Cohen-Wolkowiez M; Watt KM
Pediatr Infect Dis J; 2014 Oct; 33(10):e270-2. PubMed ID: 24776517
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
Reiter PD; Doron MW
J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic vancomycin monitoring in children with hydrocephalus during treatment of shunt infections.
Bafeltowska JJ; Buszman E; Mandat KM; Hawranek JK
Surg Neurol; 2004 Aug; 62(2):142-50; discussion 150. PubMed ID: 15261509
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
Arnell K; Enblad P; Wester T; Sjölin J
J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.
Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ
Chemotherapy; 1990; 36(2):98-102. PubMed ID: 2311446
[TBL] [Abstract][Full Text] [Related]
9. Are higher vancomycin doses needed in ventricle-external shunted patients?
Pujal M; Soy D; Codina C; Ribas J
Pharm World Sci; 2006 Aug; 28(4):215-21. PubMed ID: 17066239
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
Yang RH; Rong XZ; Hua R; Zhang T
Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
[TBL] [Abstract][Full Text] [Related]
11. Treatment of staphylococcal ventriculitis associated with external cerebrospinal fluid drains: a prospective randomized trial of intravenous compared with intraventricular vancomycin therapy.
Pfausler B; Spiss H; Beer R; Kampl A; Engelhardt K; Schober M; Schmutzhard E
J Neurosurg; 2003 May; 98(5):1040-4. PubMed ID: 12744364
[TBL] [Abstract][Full Text] [Related]
12. Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci.
Gibson A; Kaplan SL; Vallejo JG
Pediatr Neurosurg; 2018; 53(4):243-246. PubMed ID: 29698961
[TBL] [Abstract][Full Text] [Related]
13. CSF penetration of vancomycin in critical care patients with proven or suspected ventriculitis: a prospective observational study.
Blassmann U; Hope W; Roehr AC; Frey OR; Vetter-Kerkhoff C; Thon N; Briegel J; Huge V
J Antimicrob Chemother; 2019 Apr; 74(4):991-996. PubMed ID: 30689877
[TBL] [Abstract][Full Text] [Related]
14. Linezolid treatment of shunt-related cerebrospinal fluid infections in children.
Yilmaz A; Dalgic N; Müslüman M; Sancar M; Colak I; Aydin Y
J Neurosurg Pediatr; 2010 May; 5(5):443-8. PubMed ID: 20433254
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of infections of cerebrospinal fluid shunts for hydrocephalus].
Lorenzetti C; Ramadan A; Mamie C; Favier J; Berney J
Neurochirurgie; 1994; 40(4):233-41. PubMed ID: 7753294
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics in hydrocephalic shunt prophylaxis and relationship to ventricular volume.
LeRoux P; Howard MA; Winn HR
Surg Neurol; 1990 Dec; 34(6):366-72. PubMed ID: 2244299
[TBL] [Abstract][Full Text] [Related]
17. Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study.
van Lindert EJ; Bilsen MV; Flier MV; Kolwijck E; Delye H; Oever JT
PLoS One; 2018; 13(1):e0190249. PubMed ID: 29315341
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
19. Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes.
Wang KW; Chang WN; Shih TY; Huang CR; Tsai NW; Chang CS; Chuang YC; Liliang PC; Su TM; Rau CS; Tsai YD; Cheng BC; Hung PL; Chang CJ; Lu CH
Jpn J Infect Dis; 2004 Apr; 57(2):44-8. PubMed ID: 15118207
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
